BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Procaccio L, Schirripa M, Fassan M, Vecchione L, Bergamo F, Prete AA, Intini R, Manai C, Dadduzio V, Boscolo A. Immunotherapy in Gastrointestinal Cancers. Biomed Res Int. 2017;2017:4346576. [PMID: 28758114 DOI: 10.1155/2017/4346576] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Huang HW, Chang CC, Wang CS, Lin KH. Association between Inflammation and Function of Cell Adhesion Molecules Influence on Gastrointestinal Cancer Development. Cells 2021;10:E67. [PMID: 33406733 DOI: 10.3390/cells10010067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ji S, Li J, Chang L, Zhao C, Jia R, Tan Z, Liu R, Zhang Y, Li Y, Yin G, Guan Y, Xia X, Yi X, Xu J. Peripheral blood T-cell receptor repertoire as a predictor of clinical outcomes in gastrointestinal cancer patients treated with PD-1 inhibitor. Clin Transl Oncol 2021;23:1646-56. [PMID: 33583004 DOI: 10.1007/s12094-021-02562-4] [Reference Citation Analysis]
3 Lauren B, Ostvar S, Silver E, Ingram M, Oh A, Kumble L, Laszkowska M, Chu JN, Hershman DL, Manji G, Neugut AI, Hur C. Cost-Effectiveness Analysis of Biomarker-Guided Treatment for Metastatic Gastric Cancer in the Second-Line Setting. J Oncol 2020;2020:2198960. [PMID: 32148492 DOI: 10.1155/2020/2198960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Harvey JB, Phan LH, Villarreal OE, Bowser JL. CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers. Front Immunol 2020;11:508. [PMID: 32351498 DOI: 10.3389/fimmu.2020.00508] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
5 Singh D, Dheer D, Samykutty A, Shankar R. Antibody drug conjugates in gastrointestinal cancer: From lab to clinical development. J Control Release 2021;340:1-34. [PMID: 34673122 DOI: 10.1016/j.jconrel.2021.10.006] [Reference Citation Analysis]
6 Jesus VHF, Felismino TC, Barros E Silva MJ, Souza E Silva V, Riechelmann RP. Current approaches to immunotherapy in noncolorectal gastrointestinal malignancies. Clinics (Sao Paulo) 2018;73:e510s. [PMID: 30365605 DOI: 10.6061/clinics/2018/e510s] [Reference Citation Analysis]
7 Yan H, Xiao F, Zou J, Qiu C, Sun W, Gu M, Zhang L. NR4A1-induced increase in the sensitivity of a human gastric cancer line to TNFα-mediated apoptosis is associated with the inhibition of JNK/Parkin-dependent mitophagy. Int J Oncol 2018;52:367-78. [PMID: 29207128 DOI: 10.3892/ijo.2017.4216] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
8 Pan JH, Zhou H, Cooper L, Huang JL, Zhu SB, Zhao XX, Ding H, Pan YL, Rong L. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers. Front Immunol. 2019;10:6. [PMID: 30761122 DOI: 10.3389/fimmu.2019.00006] [Cited by in Crossref: 90] [Cited by in F6Publishing: 113] [Article Influence: 30.0] [Reference Citation Analysis]
9 Wu X, Qu D, Weygant N, Peng J, Houchen CW. Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments. Cancers (Basel) 2020;12:E274. [PMID: 31979136 DOI: 10.3390/cancers12020274] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
10 Dolcetti R, De Re V, Canzonieri V. Immunotherapy for Gastric Cancer: Time for a Personalized Approach? Int J Mol Sci. 2018;19:1602. [PMID: 29844297 DOI: 10.3390/ijms19061602] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
11 . UEG Week 2018 Poster Presentations. United European Gastroenterol j 2018;6. [DOI: 10.1177/2050640618792819] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
12 Li Z, Zhang X, Liu C, Ma J. Non-immune Cell Components in the Gastrointestinal Tumor Microenvironment Influencing Tumor Immunotherapy. Front Cell Dev Biol 2021;9:729941. [PMID: 34722510 DOI: 10.3389/fcell.2021.729941] [Reference Citation Analysis]
13 Yan H, Qiu C, Sun W, Gu M, Xiao F, Zou J, Zhang L. Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy. Oncol Rep 2018;39:1671-81. [PMID: 29436693 DOI: 10.3892/or.2018.6252] [Cited by in Crossref: 11] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
14 Jiang DM, Chan KKW, Jang RW, Booth C, Liu G, Amir E, Mason R, Everest L, Elimova E. Anticancer drugs approved by the Food and Drug Administration for gastrointestinal malignancies: Clinical benefit and price considerations. Cancer Med 2019;8:1584-93. [PMID: 30848108 DOI: 10.1002/cam4.2058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
15 Fang J, Ding Z. SNAI1 is a prognostic biomarker and correlated with immune infiltrates in gastrointestinal cancers. Aging (Albany NY) 2020;12:17167-208. [PMID: 32833672 DOI: 10.18632/aging.103667] [Reference Citation Analysis]
16 Liu Y, Xie S, Zhu K, Guan X, Guo L, Lu R. CALD1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers. Heliyon 2021;7:e07257. [PMID: 34189308 DOI: 10.1016/j.heliyon.2021.e07257] [Reference Citation Analysis]
17 Martin B, Märkl B. Immunologic Biomarkers and Biomarkers for Immunotherapies in Gastrointestinal Cancer. Visc Med 2019;35:3-10. [PMID: 31312644 DOI: 10.1159/000496565] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Spindler KG, Demuth C, Sorensen BS, Johansen JS, Nielsen D, Pallisgaard N, Hoegdall E, Pfeiffer P, Vittrup Jensen B. Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer. Tumour Biol 2018;40:101042831881120. [DOI: 10.1177/1010428318811207] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wu Q, Yin G, Lei J, Tian J, Lan A, Liu S. KLHL5 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Gastric Cancer. Front Mol Biosci 2020;7:599110. [PMID: 33363208 DOI: 10.3389/fmolb.2020.599110] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Zaiachuk M, Pryimak N, Kovalchuk O, Kovalchuk I. Cannabinoids, Medical Cannabis, and Colorectal Cancer Immunotherapy. Front Med (Lausanne) 2021;8:713153. [PMID: 34631734 DOI: 10.3389/fmed.2021.713153] [Reference Citation Analysis]
21 Thallinger C, Füreder T, Preusser M, Heller G, Müllauer L, Höller C, Prosch H, Frank N, Swierzewski R, Berger W, Jäger U, Zielinski C. Review of cancer treatment with immune checkpoint inhibitors : Current concepts, expectations, limitations and pitfalls. Wien Klin Wochenschr 2018;130:85-91. [PMID: 29098404 DOI: 10.1007/s00508-017-1285-9] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 10.0] [Reference Citation Analysis]
22 Dong X, Yang Z, Yang H, Li D, Qiu X. Long Non-coding RNA MIR4435-2HG Promotes Colorectal Cancer Proliferation and Metastasis Through miR-206/YAP1 Axis. Front Oncol 2020;10:160. [PMID: 32154166 DOI: 10.3389/fonc.2020.00160] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 11.5] [Reference Citation Analysis]
23 Bao D, Zhang C, Li L, Wang H, Li Q, Ni L, Lin Y, Huang R, Yang Z, Zhang Y, Hu Y. Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer. Front Oncol 2020;10:553297. [PMID: 33614473 DOI: 10.3389/fonc.2020.553297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Yang X, Pan W, Xu G, Chen L. Mitophagy: A crucial modulator in the pathogenesis of chronic diseases. Clin Chim Acta 2020;502:245-54. [PMID: 31730816 DOI: 10.1016/j.cca.2019.11.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
25 Sun Y, Pan J, Tong X, Chen E, Yan W, Wu M, Qu Q, Qu J. Glutathione S-transferases genes variants and chemotherapy efficacy in gastrointestinal cancer patients: a meta-analysis based on 50 pharmacogenetic studies. J Cancer 2019;10:2915-26. [PMID: 31281468 DOI: 10.7150/jca.31130] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
26 Yan Y, Nie K, Zheng J, Jiang X, Huang Y, Zheng Z, Wen Y, Li P. High Endothelin Receptor Type A Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Stomach Adenocarcinoma. Cancer Manag Res 2021;13:5013-26. [PMID: 34234547 DOI: 10.2147/CMAR.S313078] [Reference Citation Analysis]
27 Shi S, Ye S, Mao J, Ru Y, Lu Y, Wu X, Xu M, Zhu T, Wang Y, Chen Y, Tang X, Xi Y. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer. Autoimmunity 2020;53:210-7. [PMID: 32129682 DOI: 10.1080/08916934.2020.1735371] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Nigro O, Chini C, Proserpio I. Molecularly targeted therapy for advanced gastrointestinal noncolorectal cancer treatment: how to choose? Past, present, future. Anticancer Drugs 2021;32:593-601. [PMID: 33929995 DOI: 10.1097/CAD.0000000000001071] [Reference Citation Analysis]
29 Lazăr DC, Avram MF, Romoșan I, Cornianu M, Tăban S, Goldiș A. Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer. World J Gastroenterol 2018; 24(32): 3583-3616 [PMID: 30166856 DOI: 10.3748/wjg.v24.i32.3583] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 50] [Article Influence: 12.5] [Reference Citation Analysis]
30 Liu X, Xu Q, Li Z, Xiong B. Integrated analysis identifies AQP9 correlates with immune infiltration and acts as a prognosticator in multiple cancers. Sci Rep 2020;10:20795. [PMID: 33247170 DOI: 10.1038/s41598-020-77657-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Xiao Z, Hu L, Yang L, Wang S, Gao Y, Zhu Q, Yang G, Huang D, Xu Q. TGFβ2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer. J Cell Mol Med 2020;24:7151-62. [PMID: 32530106 DOI: 10.1111/jcmm.15164] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]